New study explores risks of inappropriate medications in older adults

NewsGuard 100/100 Score

"Potentially inappropriate medications (PIMs)" are treatments that sometimes pose risks that outweigh their benefits, particularly for people who are 65 or older.

About 20 to 60 percent of older adults take medicines that may be potentially inappropriate. That can increase the risk for being hospitalized, needing to visit the emergency department, having poor quality of life, and/or experiencing a harmful reaction.

When older adults are hospitalized for medical reasons or for surgery, they often go home with prescriptions for treatments that may be different from those they were taking beforehand.

These treatments may include PIMs. Until now, however, few studies have examined how PIMs affect older adults when prescribed at the time of their hospital discharge.

A team of researchers recently designed a study to learn more about this important issue. They examined information from medical and surgical patients to evaluate the association of PIMs (both the ones the patients had been taking earlier as well as those newly prescribed at their hospital discharge) with the risk of four outcomes.

The outcomes were harmful drug problems, emergency department visits, readmission to the hospital, and death after hospital discharge. The study was published in the Journal of the American Geriatrics Society.

This study was conducted in Quebec, Canada, where full information is available on all medical visits, emergency department visits, hospitalizations, and deaths. The researchers selected patients who were 65 years old or older and were discharged from one of the hospitals included in the study. When they were discharged, they were given prescriptions for one or more medications. Patients were followed until 30 days after their discharge or death, whichever came first.

Information from 2,402 patients was included in the study. Overall, patients were around 76 years old, had been diagnosed with five health conditions, and had been prescribed approximately eight different medications at the time of their discharge.

The researchers learned that 1,576 people--nearly two-thirds of all patients--had been prescribed at least one PIM at discharge. This included both new PIMs and/or those continued from before their hospitalization. Most patients were prescribed one PIM, and 1,176 patients were re-prescribed at least one of their previous PIMs. Nearly half of patients studied were prescribed with at least one new PIM.

Almost 10 percent of patients experienced a potentially harmful drug reaction and 36 percent visited the emergency department, were readmitted to the hospital, and/or died in the 30 days after their hospital discharge.

The researchers concluded that older adults who have been hospitalized and who are prescribed PIMs experience an increase in potentially harmful drug reactions, emergency room visits, rehospitalizations, and death within 30 days of discharge.

Source:
Journal reference:

Weir, D. L., et al. (2020) Both New and Chronic Potentially Inappropriate Medications Continued at Hospital Discharge Are Associated With Increased Risk of Adverse Events. Journal of American Geriatrics Society. doi.org/10.1111/jgs.16413.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Lurie Children's Hospital administers first gene therapy for Duchenne muscular dystrophy in Illinois